Predicting the need for adjuvant radiation therapy according to EAU guidelines among patients with unfavorable intermediate-risk prostate after radical prostatectomy

Abstract Objective: To develop and internally validate a multivariable model for preoperatively predicting the indication for adjuvant radiation therapy after radical prostatectomy according to current guideline recommendations of the European Association of Urology (EAU) in National Comprehensive Cancer Network (NCCN) unfavorable intermediate-risk prostate cancer patients. Methods: Within a high-volume center database (01/2010-08/2024), we identified NCCN unfavorable intermediate-risk prostate cancer patients. Univariable logistic regression models addressed indication for adjuvant radiation therapy according to current guideline recommendations of the EAU (2026). Multivariable logistic regression models included the most informative, statistically significant preoperative predictors. Accuracy was quantified after 2000 bootstrap resamples for internal validation with Harrell’s concordance index (c-index). Results: Of 9652 patients, 1154 (12%) had indication for adjuvant radiation therapy. Indication for adjuvant radiation therapy was associated with higher prostate volume (> 45 and 25–45 cm 3 ), higher preoperative PSA value (continuous), suspicious clinical tumor stage (cT2), higher absolute number of positive biopsy cores and higher relative proportion of positive biopsy cores (both continuous), higher Gleason Grade Group on biopsy (GGG 3) and multiple intermediate-risk factors (3 and 2). Multivariable model c-index for the prediction of the indication for adjuvant radiation therapy was 0.709 (95% CI 0.689–0.722). Conclusions: In NCCN unfavorable intermediate-risk prostate cancer patients, preoperative patient and clinical tumor characteristics can be reliably used to predict the indication for adjuvant radiation therapy after radical prostatectomy according to current EAU guideline recommendations (2026). Prior to clinical application, the present multivariable model should be externally validated.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-09
DOI
https://doi.org/10.21203/rs.3.rs-11418778/v1
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Predicting the need for adjuvant radiation therapy according to EAU guidelines among patients with unfavorable intermediate-risk prostate after radical prostatectomy

Felix K.‐H. Chun, Maximilian Filzmayer, Markus Graefen, Maximilian Kriegmair et al.
Research Square
Prostate Cancer Diagnosis and Treatment
preprint

Predicting the need for adjuvant radiation therapy according to EAU guidelines among patients with unfavorable intermediate-risk prostate after radical prostatectomy

Felix K.‐H. Chun, Maximilian Filzmayer, Markus Graefen, Maximilian Kriegmair, Carolin Siech, Thomas P Steuber, Derya Tilki A, Tobias Maurer, Felix Preißer, Mike Wenzel, Pierre Tennstedt, Tonio Brüggemann, Neele Heckmann, Philipp Mandel, Quynh Chi Le
preprint en

Abstract

Abstract Objective: To develop and internally validate a multivariable model for preoperatively predicting the indication for adjuvant radiation therapy after radical prostatectomy according to current guideline recommendations of the European Association of Urology (EAU) in National Comprehensive Cancer Network (NCCN) unfavorable intermediate-risk prostate cancer patients. Methods: Within a high-volume center database (01/2010-08/2024), we identified NCCN unfavorable intermediate-risk prostate cancer patients. Univariable logistic regression models addressed indication for adjuvant radiation therapy according to current guideline recommendations of the EAU (2026). Multivariable logistic regression models included the most informative, statistically significant preoperative predictors. Accuracy was quantified after 2000 bootstrap resamples for internal validation with Harrell’s concordance index (c-index). Results: Of 9652 patients, 1154 (12%) had indication for adjuvant radiation therapy. Indication for adjuvant radiation therapy was associated with higher prostate volume (> 45 and 25–45 cm 3 ), higher preoperative PSA value (continuous), suspicious clinical tumor stage (cT2), higher absolute number of positive biopsy cores and higher relative proportion of positive biopsy cores (both continuous), higher Gleason Grade Group on biopsy (GGG 3) and multiple intermediate-risk factors (3 and 2). Multivariable model c-index for the prediction of the indication for adjuvant radiation therapy was 0.709 (95% CI 0.689–0.722). Conclusions: In NCCN unfavorable intermediate-risk prostate cancer patients, preoperative patient and clinical tumor characteristics can be reliably used to predict the indication for adjuvant radiation therapy after radical prostatectomy according to current EAU guideline recommendations (2026). Prior to clinical application, the present multivariable model should be externally validated.

Research Square
Goethe University Frankfurt (DE), Heidelberg University (DE), University Medical Center Hamburg-Eppendorf (DE), University Hospital Frankfurt (DE)
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon